RE: AVA3996 preclinical = flat line tumour growth3 Mar 2023 15:29
Well said SB. Company can't say one thing and do another. The Open Offer was on the terms set out in the Circular. The Β£2m OO raise was a sop to PIs - although open to all current investors, including the IIs, the IIs also had the other raise, which was oversubscribed and extra shares were issued, to obtain shares at 95p.